Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Generic drug makerLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in Hong Kong SAR ChinaLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 15, 2026, FDA's public records list Lee's Pharm with 1 drug application.
Drug applications: 1
Latest Records
Newest first across sources; each opens the record
FDA's databases did not answer. Reload in a moment.
Orphan Designations (FDA)
6 designations since 1983, 0 approved for the designated use, matched by the sponsor's name; see all orphan designations
anfibatideTreatment of thrombotic thrombocytopenic purpura. · Mar 10, 2016
LucinactantTreatment of cystic fibrosis. · Oct 21, 2010
LucinactantPrevention of bronchopulmonary dysplasia in premature infants · May 23, 2006
LucinactantTreatment of bronchopulmonary dysplasia in premature infants. · Oct 21, 2005
LucinactantTreatment of respiratory distress syndrome in premature infants. · Oct 18, 1995
LucinactantTreatment of acute respiratory distress syndrome in adults. · Jul 17, 1995
Names and Identifiers
Appears as
LEES PHARM HK
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.How this page is built
